Clinical and Pharmacogenetic Factors Affecting Neonatal Bilirubinemia Following Atazanavir Treatment of Mothers During Pregnancy

A theoretical concern exists that atazanavir (ATV) use during pregnancy may exacerbate physiologic neonatal hyperbilirubinemia. The aim of this substudy was to evaluate patterns of neonatal bilirubin following ATV/ritonavir (RTV) treatment of pregnant mothers and clinical and pharmacogenetic factors...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Eley, Timothy, Huang, Shu-Pang, Conradie, Francesca, Zorrilla, Carmen D., Josipovic, Deirdre, Botes, Mariëtte, Osiyemi, Olayemi, Hardy, Hélène, Bertz, Richard, McGrath, Donnie
Formato: Artigo
Idioma:Inglês
Publicado em: Mary Ann Liebert, Inc. 2013
Assuntos:
Clinical Trials/Clinical Studies
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3785800/
https://ncbi.nlm.nih.gov/pubmed/23782005
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/aid.2013.0002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados